Are Physicians Involved with Patient Safety?* To the Editor:
The past decade has seen rapidly increasing concern over electrical safety for hospitalized patients. Ralph Nader, lawyers, regulatory agencies (local, state, federal), manufacturers are involved. Where have the physicians been?
Agencies such as the National Fire Protection Association write safety standards for electrical installations (e.g. National Electrical Code) which govern how our hospitals are built. Testing agencies such as Underwriters' Laboratories and Canadian Standards Association write standards for safe equipment construction which dictate how the equipment we use will be built. Biomedical engineering and technician programs are proliferating. However, all these approaches are largely hardware oriented, and thus either very limited, or very unlimited, in scope. Try to conceive of the difference between applying extreme safety standards to equipment likely to contact the cardiac catheterized patient and equipment likely to contact an externalized cardiac conductor. The former example can include every type of patient-related device in an institution; the latter applies to a select and reasonably welldefined set of equipment components.
The extreme standards proposed in the late 1960s are gradually turning to more attainable levels, but efforts aimed exclusively at hardware cannot totally mitigate against human problems. Indeed the specter of the "Electrically Susceptible Patient" has dominated the scene despite the fact that he can be 'eliminated' for practical purposes by simple and inexpensive methods for handling the external portions of cardiac conductors.
Why has the hardware approach set the tone for so many standards? Because standards committees are largely composed of technical people unfamiliar with details of clinical practice, and who see little professional activity toward education in basic patient safety, or development of effective safe practices. Physician input and involvement in standards-making committees has been minimal. Involvement on committees may well be restricted by lack of funding, but input into committees involves only interest and modest expense in time. The fact that accidents occur infrequently cannot continue to lull us into apathy.
Medical school curricula include basic principles of asepsis; why not safety as well? While students interested in delving deeply into these areas should be encouraged, those not so inclined should not be frightened off by involved technical courses.
The nursing profession has shown some interest in bedside patient safety, but without physician involvement their efforts can only partially succeed. I would urge professional medical organizations to emphasize to their members the importance of ensuring the following in their own institutions:
1. protecting externalized cardiac conductors from unwanted contacts with the environment;
2. selecting thoughtfully the things deliberately connected to externalized cardiac conductors. If the medical profession will concentrate on safe medical management, the technical personnel can concentrate on providing equipment and facilities reasonably and realistically safe. KAREN S. KAGEY, M. D.
Peter Bent Brigham Hospital Boston, Massachusetts
The Action of Nitroglycerin To the Editor: In a recent communication in this Journal,' Dr. Epstein's group summarized their excellent experimental studies which demonstrate that the beneficial effects of nitroglycerin in acute myocardial infarction (AMI) are augmented when nitroglycerin-induced hypotension is abolished by the peripheral vasoconstrictor methoxamine.
These findings appear to contradict the commonly held premise that the primary action of such vasodilators as nitroglycerin and sodium nitroprusside in AMI is peripheral. The improvement in myocardial function by these drugs has been explained by the sequence of peripheral vasodilation, reduction of left ventricular end-diastolic pressure, and betterment of the balance between myocardial oxygen supply and demand.2' If the primary action of nitroglycerin is peripheral vasodilation, would not the simultaneous administration of the peripheral vasoconstrictor methoxamine reduce, rather than augment, its favorable effects?
The cooperation between nitroglycerin and methoxamine provides indirect evidence that the primary action of nitroglycerin is central, with methoxamine countering its secondary peripheral vasodilative effects. A reasonable explanation for the cardiac effects of nitroglycerin is that it ablates coronary artery spasm. Apparent spasm has been demonstrated during the acute phase of experimental infarction,4 and it has been postulated5 that with clinical AMI, spasm not only initiates the AMI, but also persists during the acute phase. It is this continuing spasm that is relieved by nitroglycerin, reducing myocardial ischemia and improving cardiac function.
The evidence for spasm, although often circumstantial, is in excess of the attention the concept receives. As vasospasm probably is reversible, and possibly preventable, it appears prudent to investigate the possibility that spasm might be operative in AMI.6 H. R. HELLSTROM, M. D.
University of Pittsburgh Pittsburgh, Pennsylvania
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